Immunotherapeutic Applications of NK Cells

por Davis, Carter T., Rizzieri, David
Publicado 2015

Haploidentical Hematopoietic Stem Cell Transplantation: Expanding the Horizon for Hematologic Disorders

por Zahid, Mohammad Faizan, Rizzieri, David Alan
Publicado 2016

Anti proliferative activity of ELACYT™ (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells...

por Adams, David J., Sandvold, Marit L., Myhren, Finn, Jacobsen, Tove F., Giles, Frank, Rizzieri, David A.
Publicado 2008

Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity

por Stephens, Sarah J., Thomas, Samantha, Rizzieri, David A., Horwitz, Mitchell E., Chao, Nelson J., Engemann, Ashley M., Lassiter, Martha, Kelsey, Chris R.
Publicado 2016

Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma

por Sivaraj, Dharshan, Green, Michael M, Kang, Yubin, Long, Gwynn D, Rizzieri, David A, Li, Zhiguo, Garrett, Anderson H, McIntyre, Jackie L, Chao, Nelson J, Gasparetto, Cristina
Publicado 2018

A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid...

por Borthakur, Gautam, Odenike, Olatoyosi, Aldoss, Ibrahim, Rizzieri, David A., Prebet, Thomas, Chen, Chris, Popovic, Relja, Modi, Dimple A., Joshi, Rujuta H., Wolff, Johannes E., Jonas, Brian A.
Publicado 2021

Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation

por Kanda, Junya, Horwitz, Mitchell E., Long, Gwynn D., Gasparetto, Cristina, Sullivan, Keith M., Chute, John P., Morris, Ashley, Hennig, Therese, Li, Zhiguo, Chao, Nelson J., Rizzieri, David A.
Publicado 2011

Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial

por Sung, Anthony D., Sung, Julia A. M., Thomas, Samantha, Hyslop, Terry, Gasparetto, Cristina, Long, Gwynn, Rizzieri, David, Sullivan, Keith M., Corbet, Kelly, Broadwater, Gloria, Chao, Nelson J., Horwitz, Mitchell E.
Publicado 2016

Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm

por Pemmaraju, Naveen, Sweet, Kendra L., Stein, Anthony S., Wang, Eunice S., Rizzieri, David A., Vasu, Sumithira, Rosenblat, Todd L., Brooks, Christopher L., Habboubi, Nassir, Mughal, Tariq I., Kantarjian, Hagop, Konopleva, Marina, Lane, Andrew A.
Publicado 2022

Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia

por Zimdahl, Bryan, Ito, Takahiro, Blevins, Allen, Bajaj, Jeevisha, Konuma, Takaaki, Weeks, Joi, Koechlein, Claire S., Kwon, Hyog Young, Arami, Omead, Rizzieri, David, Broome, H. Elizabeth, Chuah, Charles, Oehler, Vivian G., Sasik, Roman, Hardiman, Gary, Reya, Tannishtha
Publicado 2014

CVD Risk Factors in the Ukrainian Roma and Meta-Analysis of Their Prevalence in Roma Populations Worldwide

por Zajc Petranović, Matea, Rizzieri, Ashley Elizabeth, Sivaraj, Dharshan, Smolej Narančić, Nina, Škarić-Jurić, Tatjana, Celinšćak, Željka, Stojanović Marković, Anita, Peričić Salihović, Marijana, Kalászi, Julia, Kalászi, Marianna, Lin, John Q., Mehta, Sanica, Burleson, Jill, Rizzieri, David A.
Publicado 2021

Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation

por Smith, Patrick J., Lew, Meagan, Lowder, Yen, Romero, Kristi, Thompson, Jillian C., Bohannon, Lauren, Pittman, Alyssa, Artica, Alexandra, Ramalingam, Sendhilnathan, Choi, Taewoong, Gasparetto, Cristina, Horwitz, Mitchell, Long, Gwynn, Lopez, Richard, Rizzieri, David, Sarantopoulos, Stefanie, Sullivan, Keith, Chao, Nelson, Sung, Anthony D.
Publicado 2022

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery

por Green, Michael M. B., Chao, Nelson, Chhabra, Saurabh, Corbet, Kelly, Gasparetto, Cristina, Horwitz, Ari, Li, Zhiguo, Venkata, Jagadish Kummetha, Long, Gwynn, Mims, Alice, Rizzieri, David, Sarantopoulos, Stefanie, Stuart, Robert, Sung, Anthony D., Sullivan, Keith M., Costa, Luciano, Horwitz, Mitchell, Kang, Yubin
Publicado 2016

Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 Mutations

por Pollyea, Daniel A., DiNardo, Courtney D., Arellano, Martha L., Pigneux, Arnaud, Fiedler, Walter, Konopleva, Marina, Rizzieri, David A., Smith, B. Douglas, Shinagawa, Atsushi, Lemoli, Roberto M., Dail, Monique, Duan, Yinghui, Chyla, Brenda, Potluri, Jalaja, Miller, Catherine L., Kantarjian, Hagop M.
Publicado 2022

PB1773: AML AND MDS WITH RARA OVEREXPRESSION: MOLECULAR AND CLINICAL FEATURES OF PATIENTS ENROLLED IN A PHASE 2 TRIAL EVALUATING TAMIBAROTENE-BASED THERAPY

por de Botton, Stéphane, Cluzeau, Thomas, Vigil, Carlos, Cook, Rachel, Rousselot, Philippe, Rizzieri, David, Liesveld, Jane, Fenaux, Pierre, Braun, Thorsten, Pigneux, Arnaud, Peterlin, Pierre, Paul, Sofia, Rajagopal, Nisha, Carulli, John, Roth, David, Volkert, Angela, Malak, Tanya Abdul, Kelly, Michael, Klimek, Virginia, Stein, Eytan
Publicado 2023

Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant

por Pabon, Cindy M., Li, Zhiguo, Hennig, Therese, de Castro, Carlos, Neff, Jadee L., Horwitz, Mitchell E., LeBlanc, Thomas W., Long, Gwynn D., Lopez, Richard D., Sung, Anthony D., Chao, Nelson, Gasparetto, Cristina, Sarantopoulos, Stefanie, Adams, Donna B., Erba, Harry, Rizzieri, David A.
Publicado 2021

Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response

por Wong, Hong Yuen, Sung, Anthony D., Lindblad, Katherine E., Sheela, Sheenu, Roloff, Gregory W., Rizzieri, David, Goswami, Meghali, Mulé, Matthew P., Ramos, Nestor R., Tang, Jingrong, Thompson, Julie, DeStefano, Christin B., Romero, Kristi, Dillon, Laura W., Kim, Dong-Yun, Lai, Catherine, Hourigan, Christopher S.
Publicado 2019

Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality

por Maung, Ko, Ramalingam, Sendhilnathan, Chaudhry, Mohammad, Ren, Yi, Jung, Sin-Ho, Romero, Kristi, Corbet, Kelly, Chao, Nelson J., Choi, Taewoong, Diehl, Anna Mae, Diehl, Louis, Gasparetto, Cristina, Horwitz, Mitchell, Long, Gwynn Douglas, Lopez, Richard D., Rizzieri, David A., Sarantopoulos, Stefanie, Sullivan, Keith M., Bashir, Mustafa R., Sung, Anthony D.
Publicado 2020

PROGNOSTIC FACTORS FOR OUTCOMES IN ALLOGENEIC TRANSPLANTATION FOR ADVANCED PHASES OF CHRONIC MYELOID LEUKEMIA IN THE IMATINIB ERA: A CIBMTR ANALYSIS

por Khoury, Hanna J, Kukreja, Manisha, Goldman, John M., Wang, Tao, Halter, Jorg, Arora, Mukta, Gupta, Vikas, Rizzieri, David A., George, Biju, Keating, Armand, Gale, Robert Peter, Marks, David I., McCarthy, Philip L., Woolfrey, Ann, Szer, Jeffrey, Giralt, Sergio A., Maziarz, Richard T., Cortes, Jorge, Horowitz, Mary M., Lee, Stephanie J
Publicado 2011

Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia

por Roboz, Gail J., Kantarjian, Hagop M., Yee, Karen W. L., Kropf, Patricia L., O'Connell, Casey L., Griffiths, Elizabeth A., Stock, Wendy, Daver, Naval G., Jabbour, Elias, Ritchie, Ellen K., Walsh, Katherine J., Rizzieri, David, Lunin, Scott D., Curio, Tania, Chung, Woonbok, Hao, Yong, Lowder, James N., Azab, Mohammad, Issa, Jean‐Pierre J.
Publicado 2017